Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Endovascular grafts recalled due to risk of coating breaking off, entering bloodstream
Customers are urged to examine their inventory, quarantine any unused products and return them to the manufacturer.
Bleeding reversal agent pulled from market over FDA’s safety concerns
AstraZeneca has stopped selling Andexxa because randomized data suggested some patients may face an increased risk of certain adverse events. The company emphasized that it remains confident in the agent's abilities.
ACC calls for better management of peripheral artery disease in diabetic patients
PAD in patients with diabetes is common and associated with an increased risk of several adverse events. A new guidance from the American College of Cardiology reviewed this topic at length, identifying areas where care needs to improve.
Surgeons use modified ‘frozen elephant trunk’ technique for first heart surgery of its kind
When the devices needed for a specific procedure were not available, a group of surgeons got creative. Their one-of-a-kind approach was a success, and the patient has experienced no complications.
New Medtronic thrombectomy system used commercially for first time
The new device uses an advanced algorithm to regulate aspiration and conserve blood. Ajit Rao, MD, a vascular surgeon with The Mount Sinai Hospital, performed the historic procedure.

Cook Medical endovascular grafts recalled due to risk of coating breaking off, entering patient’s bloodstream.

Endovascular grafts recalled due to risk of coating breaking off, entering bloodstream

Customers are urged to examine their inventory, quarantine any unused products and return them to the manufacturer.

warning safety alert recall healthcare issue

Bleeding reversal agent pulled from market over FDA’s safety concerns

AstraZeneca has stopped selling Andexxa because randomized data suggested some patients may face an increased risk of certain adverse events. The company emphasized that it remains confident in the agent's abilities.

A diabetic foot ulcer that does not heal due to low blood supply from peripheral artery disease (PAD), and the before and after interventional angiograms of the patient's revascularization treatment. Images courtesy of Foluso Fakorede, MD

ACC calls for better management of peripheral artery disease in diabetic patients

PAD in patients with diabetes is common and associated with an increased risk of several adverse events. A new guidance from the American College of Cardiology reviewed this topic at length, identifying areas where care needs to improve.

elephant trunk (FET) technique to treat a middle-aged heart patient, sharing their experience in JACC: Case Reports.[1] This is believed to be the first time surgeons have ever employed this particular approach.

Surgeons use modified ‘frozen elephant trunk’ technique for first heart surgery of its kind

When the devices needed for a specific procedure were not available, a group of surgeons got creative. Their one-of-a-kind approach was a success, and the patient has experienced no complications.

The Medtronic Liberant thrombectomy system.

New Medtronic thrombectomy system used commercially for first time

The new device uses an advanced algorithm to regulate aspiration and conserve blood. Ajit Rao, MD, a vascular surgeon with The Mount Sinai Hospital, performed the historic procedure.

Philips to acquire AI-enabled intravascular imaging specialists SpectraWAVE

Massachusetts-based SpectraWAVE has gained considerable momentum in recent years, planting its flag in some of cardiology’s biggest trends. The company was co-founded by cardiologists and has already secured multiple FDA clearances.

The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.

Is IVL safe for patients with diabetes?

New two-year data confirm that the IVL technology developed by Shockwave Medical can be used to treat diabetic patients who require PCI.

FDA recall medical device recall product recall

FDA announces Class I recall of patches used for heart surgery

There is a risk of certain pericardial patches not being as strong or durable as needed. Customers are urged to identify, quarantine and replace these devices.